Gary Hellermann

2.2k total citations
47 papers, 1.8k citations indexed

About

Gary Hellermann is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Gary Hellermann has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Physiology and 10 papers in Immunology. Recurrent topics in Gary Hellermann's work include Asthma and respiratory diseases (8 papers), DNA Repair Mechanisms (7 papers) and RNA Interference and Gene Delivery (7 papers). Gary Hellermann is often cited by papers focused on Asthma and respiratory diseases (8 papers), DNA Repair Mechanisms (7 papers) and RNA Interference and Gene Delivery (7 papers). Gary Hellermann collaborates with scholars based in United States, India and China. Gary Hellermann's co-authors include Shyam S. Mohapatra, Richard F. Lockey, Xiaoyuan Kong, Subhra Mohapatra, Weidong Zhang, Larry P. Solomonson, Sumita Behera, Daniel Billen, Homero San‐Juan‐Vergara and E. T. Sutton and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Gary Hellermann

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Hellermann United States 23 717 361 276 254 220 47 1.8k
Xia Chen China 29 1.1k 1.5× 197 0.5× 341 1.2× 156 0.6× 192 0.9× 129 2.4k
Mohammed Inayathullah United States 26 587 0.8× 371 1.0× 150 0.5× 205 0.8× 105 0.5× 54 2.0k
Yuki I. Kawamura Japan 29 876 1.2× 263 0.7× 612 2.2× 215 0.8× 302 1.4× 113 2.4k
Song Han United States 24 707 1.0× 161 0.4× 238 0.9× 93 0.4× 212 1.0× 81 1.8k
Hermann Dietrich Austria 28 997 1.4× 148 0.4× 715 2.6× 248 1.0× 251 1.1× 65 2.8k
Andrew Li United States 21 1.2k 1.7× 208 0.6× 403 1.5× 100 0.4× 256 1.2× 58 2.3k
Takayuki Okamoto Japan 26 1.1k 1.5× 196 0.5× 365 1.3× 121 0.5× 112 0.5× 67 2.1k
Meidong Liu China 24 973 1.4× 148 0.4× 292 1.1× 155 0.6× 363 1.6× 88 2.2k
Tanja Maier Germany 28 974 1.4× 412 1.1× 361 1.3× 126 0.5× 327 1.5× 65 2.5k

Countries citing papers authored by Gary Hellermann

Since Specialization
Citations

This map shows the geographic impact of Gary Hellermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Hellermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Hellermann more than expected).

Fields of papers citing papers by Gary Hellermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Hellermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Hellermann. The network helps show where Gary Hellermann may publish in the future.

Co-authorship network of co-authors of Gary Hellermann

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Hellermann. A scholar is included among the top collaborators of Gary Hellermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Hellermann. Gary Hellermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chunyan, Mark Howell, Jaya Mallela, et al.. (2013). A 3D Fibrous Scaffold Inducing Tumoroids: A Platform for Anticancer Drug Development. PLoS ONE. 8(10). e75345–e75345. 103 indexed citations
2.
Howell, Mark, et al.. (2013). Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseases. Drug Delivery and Translational Research. 3(4). 352–363. 27 indexed citations
3.
Wang, Jia-Wang, Kunyu Li, Gary Hellermann, et al.. (2011). Regulating the Regulators: microRNA and Asthma. SHILAP Revista de lepidopterología. 4(6). 94–103. 27 indexed citations
4.
Wang, Xiaoqin, Payal Raulji, Shyam S. Mohapatra, et al.. (2011). Natriuretic Peptide Receptor A as a Novel Target for Prostate Cancer. Molecular Cancer. 10(1). 56–56. 29 indexed citations
5.
Mohapatra, Shyam S., et al.. (2010). Immunotherapy for allergies and asthma: present and future. Current Opinion in Pharmacology. 10(3). 276–288. 23 indexed citations
6.
Kandasamy, Ruckmani, et al.. (2009). Isatin down-regulates expression of atrial natriuretic peptide receptor A and inhibits airway inflammation in a mouse model of allergic asthma. International Immunopharmacology. 10(2). 218–225. 22 indexed citations
7.
8.
Kong, Xiaoyuan, Gary Hellermann, Mukesh Kumar, et al.. (2005). An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Virology Journal. 2(1). 3–3. 33 indexed citations
9.
Hellermann, Gary. (2005). Book Review: A Manual for Primary Human Cell Culture. Cell Transplantation. 14(10). 859–860. 1 indexed citations
10.
Hellermann, Gary, Xiaoyuan Kong, Homero San‐Juan‐Vergara, et al.. (2004). Mechanism of bronchoprotective effects of a novel natriuretic hormone peptide. Journal of Allergy and Clinical Immunology. 113(1). 79–85. 16 indexed citations
11.
Kumar, Mukesh, Gary Hellermann, Richard F. Lockey, & Shyam S. Mohapatra. (2004). Nanoparticle-mediated gene delivery: state of the art. Expert Opinion on Biological Therapy. 4(8). 1213–1224. 61 indexed citations
12.
Zhang, Weidong, Gary Hellermann, Xiaoyuan Kong, et al.. (2004). Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. PubMed. 2(1). 8–8. 32 indexed citations
13.
Kumar, Mukesh, Xiaoyuan Kong, Aruna K. Behera, et al.. (2003). Chitosan IFN-γ-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma. PubMed. 1(1). 3–3. 88 indexed citations
14.
Price, J. M., Xuedong Chi, Gary Hellermann, & E. T. Sutton. (2001). Physiological levels ofβ-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurological Research. 23(5). 506–512. 76 indexed citations
15.
Hellermann, Gary & Larry P. Solomonson. (1997). Calmodulin Promotes Dimerization of the Oxygenase Domain of Human Endothelial Nitric-oxide Synthase. Journal of Biological Chemistry. 272(18). 12030–12034. 48 indexed citations
16.
Sutton, E. T., James G. Norman, Catherine Newton, Gary Hellermann, & Ira S. Richards. (1997). ENDOTHELIAL STRUCTURAL INTEGRITY IS MAINTAINED DURING ENDOTOXIC SHOCK IN AN INTERLEUKIN-1 TYPE 1 RECEPTOR KNOCKOUT MOUSE. Shock. 7(2). 105–110. 11 indexed citations
17.
Zhou, Quansheng, Gary Hellermann, & Larry P. Solomonson. (1995). Nitric oxide release from resting human platelets. Thrombosis Research. 77(1). 87–96. 65 indexed citations
18.
Rubin, B Y, et al.. (1988). The Development of Antibody to the Interferon-Induced Indoleamine 2,3-Dioxygenase and the Study of the Regulation of Its Synthesis. Journal of Interferon Research. 8(5). 691–702. 22 indexed citations
20.
Billen, Daniel, Gary Hellermann, & Donald R. Stallions. (1975). Role for deoxyribonucleic acid ligase in deoxyribonucleic acid polymerase i-dependent repair synthesis in toluene-treated escherichia coli. Journal of Bacteriology. 124(1). 585–588. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026